Monarch Labs, LLC
LeFlap. This new, proprietary wound dressing is specifically designed to make maggot therapy easier, quick, and simple to administer. It has been allowed by the US Food and Drug Administration for manufacturing and marketing under the trade name LeFlap, which is the first premanufactured cage dressing available for the US market. The single-piece LeFlap maggot confinement dressing is intended to prevent medicinal maggots from leaving the wound before the treatment is scheduled to end and reduce the time and cost necessary to confine them to the wound.
It consists of a bottom hydrocolloid pad that can be cut to fit the patient's wound dimensions. This foundation layer is hinged to a polyester monofilament-netted fabric coated with an adhesive. When the adhesive liner is removed, the netting will directly adhere to the hydrocolloid base to contain the maggots.
[black up pointing small triangle] Information:http://www.MonarchLabs.com